Zhengye Biotechnology Holding Limited ZYBT
1.31
0.00
0.00%
as of 25 Sep
- Market cap
- $40.1M
- P/E
- —
Follow ZYBT
| Dec '25 | Dec '24 | Dec '23 | |
|---|---|---|---|
P/FCF ratio |
0.00 | 0.00 | 0.00 |
P/Operating CF |
0.00 | 0.00 | 0.00 |
P/B ratio |
0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.43 | 0.00 | 0.00 |
EV/FCF |
0.61 | 0.00 | 0.00 |
Quick Ratio |
0.60 | 0.69 | 0.72 |
Current Ratio |
1.14 | 1.31 | 1.37 |
Net Debt/EBITDA |
(0.51) | 1.64 | 0.89 |
Debt/Assets |
17.10% | 17.52% | 17.97% |
Debt/Equity |
0.24 | 0.25 | 0.26 |
Asset Turnover |
0.26 | 0.37 | 0.00 |
Operating CF/Net income |
(0.19) | 3.63 | 1.53 |
Capex/Depreciation |
(0.49) | (1.14) | (0.44) |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| (21.66%) | 3.26% | 0.00% | |
| (15.36%) | 2.27% | 0.00% | |
ROIC |
(13.38%) | 2.45% | 7.02% |
Return on Tangible Assets |
(27.51%) | 3.81% | 9.87% |
Average Days of Receivables |
64.91 | 144.38 | 136.69 |
Research and Development Expense of Revenue |
15.48% | 6.87% | 5.62% |
Selling, General and Administrative Expense of Revenue |
64.39% | 34.26% | 31.48% |
Intangible Assets out of Total Assets |
0.13 | 0.05 | 0.05 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% |
Revenue per Share |
0.35 | 0.56 | 0.64 |
Operating CF per Share |
0.04 | 0.12 | 0.15 |
Capex per Share |
(0.04) | (0.08) | (0.03) |
Free Cash Flow per Share |
0.00 | 0.04 | 0.11 |
Cash per Share |
0.16 | 0.06 | 0.09 |
Shareholders Equity per Share |
0.93 | 1.06 | 1.02 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
0.93 | 1.06 | 1.02 |
Free Cash Flow |
0.11 | 1.83 | 5.18 |
Working Capital |
2.42 | 5.71 | 7.62 |
Capital Expenditures |
(1.81) | (3.79) | (1.45) |
Net Current Asset Value |
1.09 | 5.05 | 6.19 |
EV/EBIT |
0.00 | 0.00 | 0.00 |
Capex to Sales |
0.11 | 0.15 | 0.05 |
Net Profit Margin |
(59.99%) | 6.07% | 14.86% |
| Other line items | |||
Depreciation/Fixed assets |
0.11 | 0.09 | 0.09 |
Cash ROIC |
(51.58%) | (46.64%) | (47.01%) |
Accounts Receivable Turnover |
2.55 | 2.43 | 0.00 |
Accounts Payable Turnover |
2.17 | 2.14 | 0.00 |
Inventory Turnover |
1.95 | 1.63 | 0.00 |
Average Days of Payables |
173.74 | 164.94 | 203.71 |
Days of Inventory on Hand |
154.56 | 223.57 | 260.13 |
Average Receivables |
6.53 | 10.50 | — |
Average Payables |
6.09 | 6.08 | — |
Average Inventory |
6.79 | 8.00 | — |
Average Assets |
64.99 | 68.18 | — |
Average Common Equity |
46.08 | 47.49 | — |
Columns are period end dates